Hexcel
HXL NYSE Aerospace & Defense Financials FY2016βFY2025
Hexcel's revenue fell 0.5% to $1.9 billion in fiscal 2025. Its operating margin was 9.1%, down from 9.8% a year earlier. Free cash flow was $157 million, down 22.5%. It paid out $508 million in dividends and buybacks, 323% of free cash flow. The diluted share count fell 3.6%.
What Hexcel does
No business description yet.
- Legal name
- Hexcel Corporation
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-046377
0000717605
Revenue and margins
Hexcel had $1.9B of revenue in fiscal 2025, down 0.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β7.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $157M in fiscal 2025, 8.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Hexcel returned $508M to shareholders in fiscal 2025, 323% of free cash flow. The diluted share count fell 3.6%.
Value Hexcel yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$922M and divides by 80.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 35.9x Β· peers 103.7x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Hexcel can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $128M | $112M | $227M | $125M | $71.0M |
| Debt incl. finance leases | $825M | $724M | $700M | $701M | $993M |
| Net debt / EBITDA | 3.7x | 2.0x | 1.4x | 1.9x | 3.1x |
| Debt / equity | 0.6x | 0.5x | 0.4x | 0.5x | 0.8x |
| Interest coverage | 1.4x | 4.8x | 6.3x | 6.0x | 4.6x |
| Current ratio | 2.5x | 2.2x | 2.7x | 2.2x | 2.3x |
| Quick ratio | 1.5x | 1.3x | 1.7x | 1.2x | 1.3x |
| Total assets | $2.8B | $2.8B | $2.9B | $2.7B | $2.7B |
| Total liabilities | $1.3B | $1.3B | $1.2B | $1.2B | $1.5B |
| Shareholders' equity | $1.5B | $1.6B | $1.7B | $1.5B | $1.3B |
| Net debt (β = net cash) | $697M | $612M | $473M | $575M | $922M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$2.8M
5 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Gail E LehmanSee Remarks | Sold | 13,829 | $92.10 | $1.3M | Form 4 |
| Aug 14, 2026 | Gina FitzsimonsSee Remarks | Sold | 9,675 | $103.14 | $1.0M | Form 4 |
| Feb 27, 2026 | Amy S EvansSee Remarks | Sold | 1,500 | $92.80 | $0.1M | Form 4 |
| Oct 29, 2025 | Patrick WinterlichEVP, CFO | Sold | 3,413 | $73.34 | $0.3M | Form 4 |
| Oct 27, 2025 | Lyndon John Smithsee remarks | Sold | 2,077 | $73.02 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 7 / 9 | 6 / 9 |
| Accruals ratio | β5.3% | β5.6% | β4.5% |
| Altman Z'' | 5.65 | 5.52 | 5.10 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Hexcel HXL | $6.1B | β0.5% | 9.1% | 8.3% | 6.5% | 35.9x | 6 | |
| AeroVironment AVAV | $6.1B | 140.9% | β15.7% | β7.1% | β9.1% | β | 3 | Compare β |
| Kratos Defense & Security Solutions KTOS | $7.4B | 18.5% | 1.9% | β10.2% | 1.2% | β | 4 | Compare β |
| Axon Enterprise AXON | $34.7B | 33.5% | β2.2% | 2.7% | β2.2% | 174.4x | 6 | Compare β |
| BWX Technologies BWXT | $11.7B | 18.3% | 12.7% | 9.2% | 13.9% | 33.0x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.0B | $2.0B | $2.2B | $2.4B | $1.5B | $1.3B | $1.6B | $1.8B | $1.9B | $1.9B |
| Gross profit | $565M | $552M | $581M | $640M | $240M | $250M | $357M | $433M | $470M | $435M |
| Research and development | $46.9M | $49.4M | $55.9M | $56.5M | $46.6M | $45.1M | $45.8M | $52.7M | $57.1M | $56.4M |
| Operating income | $360M | $351M | $371M | $425M | $14.1M | $51.8M | $175M | $215M | $186M | $172M |
| Interest expense | $22.1M | $27.4M | $37.7M | $45.5M | $41.8M | $38.3M | $36.2M | $34.0M | $31.2M | $37.7M |
| Pretax income | $338M | $323M | $334M | $380M | β$27.7M | $22.0M | $150M | $110M | $155M | $135M |
| Income tax | $90.3M | $42.5M | $62.5M | $76.8M | β$61.0M | $5.9M | $31.6M | $12.1M | $22.8M | $25.6M |
| Net income | $250M | $284M | $277M | $307M | $31.7M | $16.1M | $126M | $106M | $132M | $109M |
| Diluted EPS | $2.65 | $3.09 | $3.11 | $3.57 | $0.38 | $0.19 | $1.49 | $1.24 | $1.59 | $1.37 |
| Diluted shares | 0.09B | 0.09B | 0.09B | 0.09B | 0.08B | 0.08B | 0.09B | 0.09B | 0.08B | 0.08B |
| Cash flow | ||||||||||
| Cash from operations | $401M | $429M | $421M | $491M | $264M | $152M | $173M | $257M | $290M | $231M |
| Capital expenditure | $328M | $278M | $184M | $204M | $50.6M | $27.9M | $76.3M | $108M | $87.0M | $73.3M |
| Free cash flow | $73.5M | $151M | $237M | $287M | $214M | $124M | $96.8M | $149M | $203M | $157M |
| Depreciation and amortization | $93.3M | $105M | $123M | $142M | $141M | $138M | $126M | $125M | $124M | $122M |
| Stock-based compensation | $16.1M | $17.6M | $16.2M | $18.3M | $15.4M | $19.0M | $20.0M | $20.9M | $22.2M | $14.4M |
| Acquisitions | $8.6M | $64.1M | $3.4M | $163M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $111M | $150M | $358M | $143M | $24.6M | $0.0M | $0.0M | $30.1M | $252M | $454M |
| Dividends paid | $39.8M | $42.6M | $48.4M | $4.2M | $14.2M | $0.0M | $33.7M | $42.2M | $49.3M | $53.9M |
| Dividends and buybacks | $151M | $193M | $406M | $147M | $38.8M | $0.0M | $33.7M | $72.3M | $302M | $508M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $35.2M | $60.1M | $32.7M | $64.4M | $103M | $128M | $112M | $227M | $125M | $71.0M |
| Total debt | $689M | $810M | $957M | $1.1B | $926M | $823M | $724M | $700M | $701M | $993M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $2.4M | $2.2M | $1.3M | $0.4M | $0.2M | $0.1M | $0.0M |
| Current assets | $607M | $657M | $676M | $705M | $536M | $616M | $734M | $864M | $782M | $731M |
| Current liabilities | $272M | $262M | $327M | $323M | $183M | $248M | $330M | $316M | $354M | $323M |
| Inventory | $291M | $314M | $298M | $333M | $214M | $246M | $319M | $334M | $356M | $329M |
| Property and equipment, net | $1.6B | $1.9B | $1.9B | $1.9B | $1.9B | $1.7B | $1.7B | $1.7B | $1.6B | $1.6B |
| Total assets | $2.4B | $2.8B | $2.8B | $3.1B | $2.9B | $2.8B | $2.8B | $2.9B | $2.7B | $2.7B |
| Total liabilities | $1.2B | $1.3B | $1.5B | $1.7B | $1.4B | $1.3B | $1.3B | $1.2B | $1.2B | $1.5B |
| Shareholders' equity | $1.2B | $1.5B | $1.3B | $1.4B | $1.5B | $1.5B | $1.6B | $1.7B | $1.5B | $1.3B |
| Margins | ||||||||||
| Gross margin | 28.2% | 28.0% | 26.5% | 27.2% | 16.0% | 18.9% | 22.6% | 24.2% | 24.7% | 23.0% |
| Operating margin | 18.0% | 17.8% | 17.0% | 18.1% | 0.9% | 3.9% | 11.1% | 12.0% | 9.8% | 9.1% |
| EBITDA margin | 22.6% | 23.1% | 22.6% | 24.1% | 10.3% | 14.3% | 19.1% | 19.0% | 16.3% | 15.5% |
| Net margin | 12.5% | 14.4% | 12.6% | 13.0% | 2.1% | 1.2% | 8.0% | 5.9% | 6.9% | 5.8% |
| FCF margin | 3.7% | 7.6% | 10.8% | 12.2% | 14.2% | 9.4% | 6.1% | 8.3% | 10.7% | 8.3% |
| Returns | ||||||||||
| Return on capital | 14.6% | 14.7% | 13.4% | 14.5% | 0.5% | 1.7% | 6.4% | 8.8% | 7.4% | 6.5% |
| Return on capital employed | 17.9% | 15.1% | 14.8% | 16.0% | 0.5% | 2.0% | 6.9% | 8.4% | 7.5% | 7.2% |
| Return on equity | 20.6% | 20.7% | 19.6% | 22.2% | 2.1% | 1.1% | 8.3% | 6.5% | 8.1% | 7.9% |
| Return on assets | 10.9% | 11.0% | 9.9% | 10.3% | 1.1% | 0.6% | 4.5% | 3.7% | 4.7% | 4.0% |
| Growth | ||||||||||
| Revenue growth | 7.7% | β1.6% | 10.9% | 7.6% | β36.2% | β11.8% | 19.1% | 13.4% | 6.4% | β0.5% |
| Net income growth | 5.3% | 13.7% | β2.6% | 10.9% | β89.7% | β49.2% | 684.5% | β16.3% | 25.0% | β17.2% |
| EPS growth | 8.6% | 16.6% | 0.7% | 14.8% | β89.4% | β50.0% | 684.2% | β16.8% | 28.2% | β13.8% |
| FCF growth | β | 104.9% | 57.6% | 20.9% | β25.5% | β42.1% | β21.8% | 53.8% | 36.3% | β22.5% |
| Share count change | β3.1% | β2.4% | β3.2% | β3.6% | β2.1% | 0.7% | 0.5% | 0.6% | β2.9% | β3.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.4x | 1.7x | 1.9x | 1.8x | 5.3x | 3.7x | 2.0x | 1.4x | 1.9x | 3.1x |
| Debt / equity | 0.6x | 0.5x | 0.7x | 0.7x | 0.6x | 0.6x | 0.5x | 0.4x | 0.5x | 0.8x |
| Interest coverage | 16.3x | 12.8x | 9.9x | 9.4x | 0.3x | 1.4x | 4.8x | 6.3x | 6.0x | 4.6x |
| Current ratio | 2.2x | 2.5x | 2.1x | 2.2x | 2.9x | 2.5x | 2.2x | 2.7x | 2.2x | 2.3x |
| Quick ratio | 1.2x | 1.3x | 1.2x | 1.2x | 1.8x | 1.5x | 1.3x | 1.7x | 1.2x | 1.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 16.4% | 14.1% | 8.4% | 8.7% | 3.4% | 2.1% | 4.8% | 6.1% | 4.6% | 3.9% |
| Stock comp / revenue | 0.8% | 0.9% | 0.7% | 0.8% | 1.0% | 1.4% | 1.3% | 1.2% | 1.2% | 0.8% |
| Payouts / FCF | 205.3% | 128.1% | 171.1% | 51.3% | 18.2% | 0.0% | 34.8% | 48.6% | 148.6% | 323.3% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 6.0 | 4.0 | 8.0 | 6.0 | 5.0 | 7.0 | 7.0 | 7.0 | 6.0 |
| Altman Z'' | 4.8 | 4.8 | 4.6 | 4.7 | 4.2 | 4.5 | 5.0 | 5.7 | 5.5 | 5.1 |
| Accruals ratio | β6.6% | β5.6% | β5.2% | β6.2% | β7.7% | β4.7% | β1.7% | β5.3% | β5.6% | β4.5% |
Source: SEC EDGAR XBRL filings (CIK 0000717605). Data updated October 21, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.